OPKO Health’s BioReference Laboratories and GeneDx Increase COVID-19 Response Through Expanded Testing Capacity

GeneDx’s Gaithersburg and BioReference’s Melbourne facilities offer COVID-19 testing ELMWOOD PARK, N.J., April 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced its subsidiary GeneDx will begin testing for COVID-19 to further expand public access to testing. In addition, BioReference will leverage its Melbourne, Florida facility to increase COVID-19 testing capacity, […]

GeneDx Turns 20

We’re celebrating something BIG today – our specialty genetics laboratory, GeneDx, turns 20! If you haven’t heard of GeneDx, they are a global leader and pioneer in advanced genetic and genomics testing, and specialize in diagnosing rare and ultra-rare disorders. With over 300 million people in the world living with a rare disease, GeneDx’s 20 […]

BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic Disorders

Elmwood Park, NJ, Nov. 04, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and women’s health division, GenPath, today announced the presentation of new research from its genetics program at the National Society for Genetic Counselors (NSGC) 38th Annual Conference in Salt Lake City, […]